Dr Verena Carrara
Verena is a research clinician based in SMRU since 2001. The focus of her work was initially on malaria epidemiology: evaluating the impact of large scale deployment of early diagnosis and treatment with artemisin-based combination therapy; monitoring the changes in efficacy of 3-day mefloquine-artesunate treatment; measuring the malaria incidence in the pregnant population.
Her work later shifted on maternal and child health, in particular the role of maternal infections and nutritional status in relation to birth outcome, child’s growth, anaemia and neurocognitive development in the 2 first years of life.
Outcomes for 298 breastfed neonates whose mothers received ketamine and diazepam for postpartum tubal ligation in a resource-limited setting
Gilder ME. et al, (2021), BMC Pregnancy and Childbirth, 21
A randomized controlled trial of dihydroartemisinin-piperaquine, artesunate-mefloquine and extended artemether-lumefantrine treatments for malaria in pregnancy on the Thailand-Myanmar border.
Saito M. et al, (2021), BMC medicine, 19
Fetal cranial growth trajectories are associated with growth and neurodevelopment at 2 years of age: INTERBIO-21st Fetal Study
Villar J. et al, (2021), Nature Medicine, 27, 647 - 652
Short maternal stature and gestational weight gain among refugee and migrant women birthing appropriate for gestational age term newborns: a retrospective cohort on the Myanmar-Thailand border, 2004-2016.
Lee SJ. et al, (2021), BMJ global health, 6
The risk of Plasmodium vivax parasitaemia after P. falciparum malaria: An individual patient data meta-analysis from the WorldWide Antimalarial Resistance Network
Hossain MS. et al, (2020), PLOS Medicine, 17, e1003393 - e1003393